20182019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Raffale Conca is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 30 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Is there still a place for vinorelbine in advanced metastatic castration resistant prostate cancer?

Roviello, G., Corona, S. P., Conca, R., Petrioli, R., Rosellini, P., Bonetta, A. & Aieta, M., Jun 1 2019, In : Medicine. 98, 26, p. e16249

Research output: Contribution to journalArticle

Open Access
  • The influence of prior ramucirumab treatment on the clinical activity of FOLFIRI as third-line therapy in patients with metastatic gastric Cancer

    Roviello, G., Petrioli, R., Rosellini, P., Multari, A. G., Conca, R., Paganini, G., Chiriacò, G. & Aieta, M., Jun 15 2019, In : Investigational New Drugs. 37, 3, p. 524-530 7 p.

    Research output: Contribution to journalArticle

  • Association between ramucirumab-related hypertension and response to treatment in patients with metastatic gastric cancer

    Roviello, G., Corona, S. P., Multari, A. G., Paganini, G., Chiriacò, G., Conca, R., Petrioli, R., Generali, D., Rosellini, P. & Aieta, M., Apr 27 2018, In : Oncotarget. 9, 32, p. 22332-22339 8 p.

    Research output: Contribution to journalArticle

  • Corticosteroid switch in heavily pre-treated castration-resistant prostate cancer patients progressed on abiraterone acetate plus prednisone

    Roviello, G., Petrioli, R., Bonetta, A., Conca, R., Rodriquenz, M. G. & Aieta, M., Dec 1 2018, In : Investigational New Drugs. 36, 6, p. 1110-1115 6 p.

    Research output: Contribution to journalArticle